In vivo model for the evaluation of molecules active towards transmissible spongiform encephalopathies

Veterinary Research Communications

Volumn 28, Issue SUPPL. 1, 2004, Pages 307-310

  Ponti, Wilma ^a   Sala, M ^b   Pollera, C ^a   Braida, D ^b   Poli, G ^a   Bareggi, S ^b  

^a Igiene e Sanita Pubblica Veterinaria   (Italy)

^b Dipartimento di Farmacologia   (Italy)

Author keywords

Anti prionic therapy; Clioquinol; General behaviour observations; Hamster; In vivo models

Indexed keywords

CLIOQUINOL; ENTEROVIORFORMIO;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; EXPERIMENTAL INFECTION; HAMSTER; IN VIVO STUDY; MEMORY; MOTOR ACTIVITY; NONHUMAN; PASSIVE AVOIDANCE; PRION DISEASE; SCRAPIE; SURVIVAL;

ANIMALS; ANTI-INFECTIVE AGENTS; AVOIDANCE LEARNING; CLIOQUINOL; CRICETINAE; DISEASE MODELS, ANIMAL; MESOCRICETUS; MOTOR ACTIVITY; PRION DISEASES; PRIONS; SURVIVAL ANALYSIS;

ANIMALIA; CRICETINAE;

EID: 5644239891     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:VERC.0000045433.45346.1c     Document Type: Article

References (5)

1. Braida, D. Pozzi, M. and Sala, M., 2000. CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils. Neuroscience Letters, 296(2-3), 69-72
2. Brown P., 2002. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology. 58(12), 1720-1725
3. Cuajungco, M.P., Faget, K.Y., Huang, X., Tanzi, R.E. and Bush, A.I., 2000. Metal chelation as a potential therapy for Alzheimer's disease. Annals of the New York Academy of Sciences, 920, 292-304
4. Melov S., 2002, '... and C is for Clioquinol' - the AbetaCs of Alzheimer's disease. Trends in Neurosciences, 25(3), 121-123
5. Sala, M., Leone, M.P., Lampugnani, P., Matturri, L. and Gori, E., 1997. Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil. European Journal of Pharmacology, 328(2-3), 143-152